290 related articles for article (PubMed ID: 25483649)
1. Active specific immunotherapy: using tumor heterogeneity to successfully fight cancer.
Hanna MG; Howard J; Vermorken J
Hum Vaccin Immunother; 2014; 10(11):3286-96. PubMed ID: 25483649
[No Abstract] [Full Text] [Related]
2. Strategies for immunotherapy of cancer.
Melief CJ; Toes RE; Medema JP; van der Burg SH; Ossendorp F; Offringa R
Adv Immunol; 2000; 75():235-82. PubMed ID: 10879286
[No Abstract] [Full Text] [Related]
3. Tumor-specific antigens and immunologic adjuvants in cancer immunotherapy.
Seremet T; Brasseur F; Coulie PG
Cancer J; 2011; 17(5):325-30. PubMed ID: 21952282
[TBL] [Abstract][Full Text] [Related]
4. Human Tumor Antigens and Cancer Immunotherapy.
Vigneron N
Biomed Res Int; 2015; 2015():948501. PubMed ID: 26161423
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer vaccines: current status.
Hwang LC; Fein S; Levitsky H; Nelson WG
Semin Oncol; 1999 Apr; 26(2):192-201. PubMed ID: 10597730
[TBL] [Abstract][Full Text] [Related]
6. Tumor immunology top 10 list.
Finn OJ
Immunol Rev; 2008 Apr; 222():5-8. PubMed ID: 18363991
[No Abstract] [Full Text] [Related]
7. Cancer vaccines.
Butterfield LH
BMJ; 2015 Apr; 350():h988. PubMed ID: 25904595
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of metastasis.
Dallal RM; Lotze MT
Surg Oncol Clin N Am; 2001 Apr; 10(2):433-47, xi. PubMed ID: 11382596
[TBL] [Abstract][Full Text] [Related]
9. Targeting targeted therapies.
Shingler W; Harrop R
Immunotherapy; 2010 Nov; 2(6):745-8. PubMed ID: 21091104
[No Abstract] [Full Text] [Related]
10. Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target.
Zbar AP; Lemoine NR; Wadhwa M; Thomas H; Snary D; Kmiot WA
Br J Cancer; 1998 Mar; 77(5):683-93. PubMed ID: 9514045
[No Abstract] [Full Text] [Related]
11. Anti-idiotype vaccine against cancer.
Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
Immunol Lett; 2000 Sep; 74(1):51-8. PubMed ID: 10996628
[TBL] [Abstract][Full Text] [Related]
12. [Cancer immunotherapy--current status].
Kundig TM; Renner Ch; Knuth A
Ther Umsch; 2006 Apr; 63(4):262-6. PubMed ID: 16689457
[TBL] [Abstract][Full Text] [Related]
13. Introduction: current concepts in immunity to human cancer and therapeutic antitumor vaccines.
Dupont B
Immunol Rev; 2002 Oct; 188():5-8. PubMed ID: 12445276
[No Abstract] [Full Text] [Related]
14. [Tumor vaccination using monoclonal antibodies].
Veelken H
Internist (Berl); 2001 Jun; 42(6):874-83. PubMed ID: 11449634
[No Abstract] [Full Text] [Related]
15. Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle-Invasive Bladder Cancer Patients.
Derré L; Cesson V; Lucca I; Cerantola Y; Valerio M; Fritschi U; Vlamopoulos Y; Burruni R; Legris AS; Dartiguenave F; Gharbi D; Martin V; Vaucher L; Speiser DE; Romero P; Jichlinski P; Nardelli-Haefliger D
Clin Cancer Res; 2017 Feb; 23(3):717-725. PubMed ID: 27521445
[TBL] [Abstract][Full Text] [Related]
16. Can we predict mutant neoepitopes in human cancers for patient-specific vaccine therapy?
Lutz ER; Jaffee EM
Cancer Immunol Res; 2014 Jun; 2(6):518-21. PubMed ID: 24795140
[No Abstract] [Full Text] [Related]
17. Tumor immunology.
Stevenson H; Tsang KY
Immunol Ser; 1993; 58():497-515. PubMed ID: 8424991
[No Abstract] [Full Text] [Related]
18. T-cell epitope peptide vaccines.
Elsawa SF; Rodeberg DA; Celis E
Expert Rev Vaccines; 2004 Oct; 3(5):563-75. PubMed ID: 15485336
[TBL] [Abstract][Full Text] [Related]
19. Are mimotope vaccines a good alternative to monoclonal antibodies?
Pourjafar M; Samadi P; Khoshinani HM; Saidijam M
Immunotherapy; 2019 Jun; 11(9):795-800. PubMed ID: 31094256
[TBL] [Abstract][Full Text] [Related]
20. Immune therapy for cancer.
Dougan M; Dranoff G
Annu Rev Immunol; 2009; 27():83-117. PubMed ID: 19007331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
